Top Inventors for class "Drug, bio-affecting and body treating compositions" |
Rank | Inventor's name | Country | City/State | Last publication | # of patent apps in this class |
1 | Anthony W. Czarnik | US | Reno, NV | Jan 06, 2022 / 20220000851 - DEUTERIUM-ENRICHED PIOGLITAZONE | 253 |
2 | Ulrike Wachendorff-Neumann | DE | Neuwied | Oct 21, 2021 / 20210321615 - ACTIVE COMPOUND COMBINATIONS CONTAINING A THIAZOYLISOXAZOLINE AND A FUNGICIDE | 157 |
3 | Ken Chow | US | Newport Coast, CA | Jun 22, 2017 / 20170172982 - METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS | 129 |
4 | John E. Donello | US | Dana Point, CA | Jul 28, 2022 / 20220233505 - PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES | 127 |
5 | Rajinder Singh | US | Belmont, CA | Sep 22, 2022 / 20220296601 - TREATMENT OF FOCAL SEGMENTAL GLOMERULOSCLEROSIS WITH CCR2 ANTAGONISTS | 108 |
6 | Michael E. Garst | US | Newport Beach, CA | Jun 30, 2022 / 20220202777 - AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | 103 |
7 | Dan Peters | SE | Malmo | Aug 21, 2014 / 20140235669 - CHROMEN-2-ONE DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS | 101 |
8 | Dorian Bevec | DE | Germering | Mar 17, 2011 / 20110065630 - USE OF A OCTREOTIDE AS A THERAPEUTIC AGENT | 100 |
9 | Peter Dahmen | DE | Neuss | Jun 17, 2021 / 20210176992 - FUNGICIDALLY ACTIVE COMBINATION OF A CLONOSTACHYS STRAIN AND AN AZOLE | 99 |
10 | Thomas G. Gant | US | Carlsbad, CA | Aug 25, 2022 / 20220267317 - Benzoquinoline Inhibitors of Vesicular Monoamine Transporter 2 | 96 |
11 | Frank Himmelsbach | DE | Mittelbiberach | Jun 09, 2016 / 20160159784 - N-CYCLOPROPYL-N-PIPERIDINYL-AMIDES, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USES THEREOF | 85 |
12 | Arnd Voerste | DE | Koln | Sep 14, 2017 / 20170260183 - BICYCLIC COMPOUNDS AS PEST CONTROL AGENTS | 76 |
13 | Joseph Collard | US | Delray Beach, FL | Sep 17, 2020 / 20200291407 - TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF | 76 |
14 | Olga Khorkova Sherman | US | Tequesta, FL | Sep 17, 2020 / 20200291407 - TREATMENT OF GLIAL CELL DERIVED NEUROTROPHIC FACTOR (GDNF) RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO GDNF | 75 |
15 | Philippe Desbordes | FR | Lyon | Dec 16, 2021 / 20210387964 - HETEROARYLAMINOQUINOLINES AND ANALOGUES | 74 |
16 | Reiner Fischer | DE | Monheim | Dec 30, 2021 / 20210400966 - NEW ALKYNYL-SUBSTITUTED 3-PHENYLPYRROLIDINE-2,4-DIONES AND USE THEREOF AS HERBICIDES | 72 |
17 | Wha Bin Im | US | Irvine, CA | Jun 01, 2017 / 20170151261 - SKIN WOUND HEALING AND SCAR REDUCTION WITH PROSTAGLANDIN EP4 AGONIST COMBINATIONS | 71 |
18 | Pascal Furet | FR | Thann | Jun 30, 2016 / 20160185733 - COMPOUNDS AND COMPOSITIONS FOR INHIBITING THE ACTIVITY OF ABL1, ABL2 AND BCR-ABL1 | 69 |
19 | Matthias Nettekoven | DE | Grenzach-Wyhlen | Dec 29, 2016 / 20160376262 - NOVEL PYRIDINE DERIVATIVES | 69 |
20 | Daniel W. Gil | US | Corona Del Mar, CA | Sep 15, 2022 / 20220288031 - ALPHA-2-ADRENERGIC RECEPTOR AGONISTS FOR IMPROVING VISION | 69 |
21 | Craig W. Lindsley | US | Brentwood, TN | Jul 07, 2022 / 20220213069 - ANTAGONISTS OF THE MUSCARINIC ACETYLCHOLINE RECEPTOR M4 | 68 |
22 | Peter D.j. Grootenhuis | US | San Diego, CA | Nov 17, 2016 / 20160332997 - MODULATORS OF ATP-BINDING CASSETTE TRANSPORTERS | 66 |
23 | Susan M. Freier | US | San Diego, CA | Sep 22, 2022 / 20220298200 - COMPOUNDS AND METHODS FOR MODULATING ANGIOTENSINOGEN EXPRESSION | 66 |
24 | Jinglan Zhou | US | San Diego, CA | Feb 04, 2021 / 20210032272 - MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR, PHARMACEUTICAL COMPOSITIONS, METHODS OF TREATMENT, AND PROCESS FOR MAKING THE MODULATOR | 65 |
25 | Johannes-Peter Stasch | DE | Solingen | Sep 14, 2017 / 20170260139 - NOVEL 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS AND THEIR USE | 64 |
26 | Pierre-Yves Coqueron | FR | Lyon | Feb 04, 2021 / 20210030002 - USE OF PYDIFLUMETOFEN FOR THE REDUCTION OF MYCOTOXIN CONTAMINATION IN PLANTS | 62 |
27 | Liliane Unger | DE | Ludwigshafen | Sep 14, 2017 / 20170260158 - QUINOLINE COMPOUNDS SUITABLE FOR TREATING DISORDERS THAT RESPOND TO THE MODULATION OF THE SEROTONIN 5-HT6 RECEPTOR | 61 |
28 | Hector F. Deluca | US | Deerfield, WI | Aug 20, 2020 / 20200262773 - PROCEDURE FOR CRYSTALLIZATION OF (22E)-(24R)-2-METHYLENE-22-DEHYDRO-1A,24-25-TRIHYDROXY-19-NOR-VITAMIN D3 | 61 |
29 | Heike Hungenberg | DE | Langenfeld | May 12, 2016 / 20160128331 - ANTHRANILAMIDES IN COMBINATION WITH FUNGICIDES | 60 |
30 | Yi Liu | US | San Diego, CA | Aug 25, 2022 / 20220265637 - CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | 60 |
31 | Pingda Ren | US | San Diego, CA | Aug 25, 2022 / 20220265637 - CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | 59 |
32 | Dieter Dorsch | DE | Ober-Ramstadt | Aug 25, 2022 / 20220267320 - 4-(IMIDAZO[1,2-A]PYRIDIN-3-YL)-PYRIMIDINE DERIVATIVES | 59 |
33 | Leonid Beigelman | US | San Mateo, CA | Sep 01, 2022 / 20220275366 - RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (SINA) | 59 |
34 | James Mcswiggen | US | Boulder, CO | Sep 25, 2014 / 20140288148 - RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING CHEMICALLY MODIFIED SHORT INTERFERING NUCLEIC ACID (siNA) | 59 |
35 | Sarvajit Chakravarty | US | Mountain View, CA | Oct 14, 2021 / 20210317140 - Heterocyclic Compounds and Methods of Use | 58 |
36 | Sepehr Sarshar | US | Cardiff By The Sea, CA | Sep 10, 2015 / 20150250777 - SUBSTITUTED N-ARYL PYRIDINONES | 58 |
37 | Jeff Zablocki | US | Los Altos, CA | Jul 14, 2022 / 20220218709 - TOLL LIKE RECEPTOR MODULATOR COMPOUNDS | 57 |
38 | Elena Feinstein | IL | Rehovot | Jun 22, 2017 / 20170175115 - METHOD FOR TREATING FIBROSIS USING SIRNA AND A RETINOID-LIPID DRUG CARRIER | 57 |
39 | Lijun Sun | US | Harvard, MA | Sep 08, 2022 / 20220281802 - COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF THEIR USE IN THE INHIBITION OF INTERACTION BETWEEN IL18 AND IL18R | 56 |
40 | Suresh B. Singh | US | Kendall Park, NJ | Jun 17, 2021 / 20210179611 - INHIBITORS OF THE MENIN-MLL INTERACTION | 55 |
41 | Jurgen Benting | DE | Leichlingen | Jan 28, 2016 / 20160023987 - BENZOCYCLOALKENES AS ANTIFUNGAL AGENTS | 55 |
42 | Gerald Bacher | DE | Germering | Jul 10, 2014 / 20140193519 - INDIBULIN THERAPY | 54 |
43 | David W. Old | US | Irvine, CA | Nov 26, 2015 / 20150336940 - THERAPEUTIC SUBSTITUTED PYRROLES | 54 |
44 | Karl-Heinz Schlemmer | DE | Wuppertal | May 12, 2016 / 20160129004 - SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE | 53 |
45 | Frank Wunder | DE | Wuppertal | Sep 01, 2022 / 20220274958 - SUBSTITUTED PYRAZOLO PIPERIDINE CARBOXYLIC ACIDS | 53 |
46 | Vera Cavalli | CH | Muzzano | Mar 17, 2011 / 20110065630 - USE OF A OCTREOTIDE AS A THERAPEUTIC AGENT | 53 |
47 | Fabio Cavalli | CH | Beckenried | Mar 17, 2011 / 20110065630 - USE OF A OCTREOTIDE AS A THERAPEUTIC AGENT | 52 |
48 | Lee Honigberg | US | San Francisco, CA | Jan 13, 2022 / 20220008424 - INHIBITORS OF BRUTON'S TYROSINE KINASE | 52 |
49 | Eric E. Swayze | US | Encinitas, CA | Sep 01, 2022 / 20220275365 - COMPOSITIONS AND METHODS FOR MODULATING TTR EXPRESSION | 52 |
50 | Prabha N. Ibrahim | US | Mountain View, CA | Nov 18, 2021 / 20210353602 - COMPOUNDS AND METHODS FOR KINASE MODULATION, AND INDICATIONS THEREFOR | 51 |
51 | Paul R. Fatheree | US | San Francisco, CA | Sep 15, 2022 / 20220289737 - FUSED IMIDAZO-PIPERIDINE JAK INHIBITORS | 51 |
52 | Scott D. Kuduk | US | Harleysville, PA | Aug 04, 2022 / 20220242879 - FUSED HETEROCYCLE DERIVATIVES | 51 |
53 | Wenkui K. Fang | US | Irvine, CA | Jun 22, 2017 / 20170172982 - METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS | 51 |
54 | Lori A. Plum | US | Arena, WI | Feb 16, 2017 / 20170042913 - USE OF 2-METHYLENE-19-NOR-(20S)-1ALPHA,25-DIHYDROXYVITAMIN D3 TO TREAT SECONDARY HYPERPARATHYROIDISM IN PATIENTS PREVIOUSLY TREATED WITH CALCIMIMETICS | 49 |
55 | Rajendra Parasmal Jain | IN | Pune | Feb 04, 2016 / 20160030446 - PYRIDO [4,3-B]INDOLE AND PYRIDO [3,4-B] INDOLE DERIVATIVES AND METHODS OF USE | 49 |
56 | Margaret Clagett-Dame | US | Deerfield, WI | Aug 20, 2020 / 20200262773 - PROCEDURE FOR CRYSTALLIZATION OF (22E)-(24R)-2-METHYLENE-22-DEHYDRO-1A,24-25-TRIHYDROXY-19-NOR-VITAMIN D3 | 49 |
57 | Shoujun Chen | US | Bedford, MA | May 18, 2017 / 20170136085 - TARGETED THERAPEUTICS | 49 |
58 | Sanjay Bhanot | US | Carlsbad, CA | Jun 15, 2017 / 20170166899 - COMPOSITIONS AND METHODS FOR MODULATING GROWTH HORMONE RECEPTOR EXPRESSION | 48 |
59 | Thorsten Oost | DE | Biberach An Der Riss | Jan 14, 2021 / 20210009627 - CYCLIC DINUCLEOTIDE COMPOUNDS CONTAINING 2-AZA-HYPOXANTHINE OR 6H-PYTAZOLO[1,5-D][1,2,4]TRIZAIN-7-ONE AS STRING AGONISTS | 47 |
60 | Jeffrey P. Whitten | US | Santee, CA | Feb 16, 2017 / 20170044152 - COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM | 47 |
61 | David A. Claremon | US | Maple Glen, PA | Jun 17, 2021 / 20210179611 - INHIBITORS OF THE MENIN-MLL INTERACTION | 47 |
62 | Chi B. Vu | US | Arlington, MA | May 28, 2015 / 20150148343 - CHROMENONE ANALOGS AS SIRTUIN MODULATORS | 47 |
63 | P. Jeffrey Conn | US | Brentwood, TN | Sep 17, 2020 / 20200291019 - INDAZOLE COMPOUNDS AS MGLUR4 ALLOSTERIC POTENTIATORS, COMPOSITIONS, AND METHODS OF TREATING NEUROLOGICAL DYSFUNCTION | 47 |
64 | Marie-Claire Grosjean-Cournoyer | FR | Curis Au Mont D'Or | Sep 24, 2015 / 20150264927 - METHOD FOR TREATING PLANTS AGAINST FUNGI RESISTANT TO FUNGICIDES USING CARBOXAMIDE OR THIOCARBOXAMIDE DERIVATIVES | 46 |
65 | Thomas Pitterna | CH | Stein | Sep 15, 2022 / 20220289715 - PESTICIDALLY ACTIVE PYRAZINE-AMIDE COMPOUNDS | 46 |
66 | Allergan, Inc. | US | Irvine, CA | Aug 08, 2013 / 20130203854 - ENHANCED BIMATOPROST OPHTHALMIC SOLUTION | 46 |
67 | Henri Doods | DE | Warthausen | Aug 20, 2020 / 20200262830 - NOVEL (CYANO-DIMETHYL-METHYL)-ISOXAZOLES AND -[1,3,4]THIADIAZOLES | 46 |
68 | John F. Kadow | US | Wallingford, CT | Sep 17, 2020 / 20200291002 - BENZOFURAN DERIVATIVES FOR THE TREATMENT OF HEPATITIS C | 46 |
69 | Richard Chesworth | US | Concord, MA | Dec 09, 2021 / 20210379076 - ARYL-OR HETEROARYL-SUBSTITUTED BENZENE COMPOUNDS | 46 |
70 | Liming Wang | US | Irvine, CA | Feb 18, 2016 / 20160045489 - N-(IMIDAZOLIDIN-2-YLIDENE)QUINOLINE DERIVATIVES AS MODULATORS OF ALPHA 2 ADRENERGIC RECEPTORS | 46 |
71 | Laykea Tafesse | US | Robbinsville, NJ | Sep 08, 2022 / 20220280527 - TRACE AMINE ASSOCIATED RECEPTOR 1 AGONISTS AND PARTIAL AGONISTS FOR PAIN TREATMENT | 45 |
72 | Olga Malsam | DE | Rosrath | Sep 17, 2020 / 20200288710 - SUBSTITUTED SULPHONAMIDES FOR CONTROLLING ANIMAL PESTS | 45 |
73 | Henner Knust | DE | Rheinfelden | Oct 01, 2015 / 20150274661 - INDOL-AMIDE COMPOUNDS AS BETA-AMYLOID INHBITORS | 45 |
74 | Richard L. Beard | US | Newport Beach, CA | Jun 30, 2022 / 20220202777 - AMIDE DERIVATIVES OF N-UREA SUBSTITUTED AMINO ACIDS AS FORMYL PEPTIDE RECEPTOR LIKE-1 (FPRL-1) RECEPTOR MODULATORS | 45 |
75 | William J. Greenlee | US | Teaneck, NJ | Aug 11, 2022 / 20220251084 - PROGRANULIN MODULATORS AND METHODS OF USING THE SAME | 45 |
76 | Ulrich GĂ–rgens | DE | Ratingen | Nov 21, 2013 / 20130310254 - Alpha, beta-unsaturated imines | 45 |
77 | Jesper Lau | DK | Farum | Apr 21, 2016 / 20160108102 - Novel GLP-1 Derivatives | 45 |
78 | C. Frank Bennett | US | Carlsbad, CA | Feb 04, 2021 / 20210032624 - Compositions and Methods for Modulation of SMN2 Splicing in a Subject | 45 |
79 | Scott L. Harbeson | US | Cambridge, MA | Oct 28, 2021 / 20210330674 - DEUTERATED DERIVATIVES OF RUXOLITINIB | 44 |
80 | Anandan Palani | US | Bridgewater, NJ | May 26, 2016 / 20160143895 - HETEROCYCLIC COMPOUNDS AND METHODS OF USE THEREOF FOR THE TREATMENT OF HEPATITIS C | 44 |
81 | Todd M. Heidelbaugh | US | Fountain Valley, CA | Jun 22, 2017 / 20170172982 - METHODS OF TREATING ALPHA ADRENERGIC MEDIATED CONDITIONS | 44 |
82 | Erik Verner | US | Belmont, CA | Mar 10, 2022 / 20220073522 - Substituted Pyrazolo[3,4-d]Pyrimidines as Kinase Inhibitors | 44 |
83 | Riccardo Giovannini | IT | Verona | Jan 06, 2022 / 20220002310 - CCR2 RECEPTOR ANTAGONISTS AND USES THEREOF | 44 |
84 | Mark Rogers-Evans | CH | Bottmingen | Jun 15, 2017 / 20170166534 - RADIOLABELED CANNABINOID RECEPTOR 2 LIGAND | 44 |
85 | Thomas Seitz | DE | Langenfeld | Apr 19, 2018 / 20180103641 - HETEROARYLPIPERIDINE AND -PIPERAZINE DERIVATIVES AS FUNGICIDES | 44 |
86 | Herriot Tabuteau | US | New York, NY | Sep 08, 2022 / 20220280524 - REBOXETINE TO TREAT NARCOLEPSY | 44 |
87 | James N. Chang | US | Newport Beach, CA | Oct 21, 2021 / 20210322318 - PROCESSES FOR MAKING CYCLIC LIPID IMPLANTS FOR INTRAOCULAR USE | 44 |
88 | Bandi Parthasaradhi Reddy | IN | Hyderabad | Mar 19, 2020 / 20200087342 - C-3 NOVEL TRITERPENONE WITH C-17 REVERSE AMIDE DERIVATIVES AS HIV INHIBITORS | 43 |
89 | Mark G. Currie | US | Sterling, MA | May 19, 2016 / 20160136111 - TREATMENT OF CNS DISORDERS WITH trans 4-(3,4-DICHLOROPHENYL)-1,2,3,4-TETRAHYDRO-1-NAPHTHALENAMINE | 43 |
90 | Richard D. Dimarchi | US | Carmel, IN | Apr 19, 2018 / 20180105569 - ANALOGS OF GLUCAGON EXHIBITING GIP RECEPTOR ACTIVITY | 43 |
91 | Paresh Soni | US | Mystic, CT | Aug 04, 2022 / 20220241234 - METHODS OF TREATING MIXED DYSLIPIDEMIA | 43 |
92 | Anjali Pandey | US | Fremont, CA | Sep 08, 2022 / 20220281885 - TYK2 INHIBITORS AND USES THEREOF | 43 |
93 | Benedikt Vollrath | US | San Diego, CA | Oct 07, 2021 / 20210311077 - ALPHA-SYNUCLEIN DETECTION USING BEADS | 43 |
94 | Hoffmann-La Roche Inc. | US | Nutley, NJ | Aug 08, 2013 / 20130203728 - PYRROLIDINE COMPOUNDS | 42 |
95 | Peter Renold | CH | Stein | Mar 19, 2020 / 20200087292 - PESTICIDALLY ACTIVE AZETIDINE SULFONES AMIDE ISOXAZOLINE DERIVATIVES | 42 |
96 | Liansheng Li | US | San Diego, CA | Aug 25, 2022 / 20220265637 - CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS | 42 |
97 | Dieter Lang | DE | Velbert | Sep 14, 2017 / 20170260139 - NOVEL 5-AMINOTETRAHYDROQUINOLINE-2-CARBOXYLIC ACIDS AND THEIR USE | 42 |
98 | Gregory T. Went | US | Mill Valley, CA | Jun 01, 2017 / 20170151190 - AMANTADINE COMPOSITIONS AND METHODS OF USE | 42 |
99 | Thomas Christoph | DE | Aachen | Sep 12, 2019 / 20190274974 - Treatment of Pain Associated with Trigeminal Neuralgia | 42 |
100 | James P. Edwards | US | San Diego, CA | Sep 14, 2017 / 20170258782 - ALKYL LINKED QUINOLINYL MODULATORS OF ROR.gamma.t | 42 |